Picture of Accolade logo

ACCD Accolade Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Accolade, fiscal year end - February 29th, USD millions except per share, conversion factor applied.

2020
February 29th
2021
February 28th
2022
February 28th
2023
February 28th
2024
February 29th
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-51.4-50.7-123-460-99.8
Depreciation
Deferred Taxes
Non-Cash Items1413.532.137858.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.43.72-7.84-1.14-20
Change in Accounts Receivable
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-34.2-25.2-62.4-40.7-16.2
Capital Expenditures-3.31-2.37-3.62-7.23-12.5
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.206-0.058-2600-51.1
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3.52-2.42-264-7.23-63.6
Financing Cash Flow Items-0.753-42.9-1.83-0.355
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities28.24282583.16-55.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-9.55401-68-44.8-135